HomeCompareODMCX vs JNJ

ODMCX vs JNJ: Dividend Comparison 2026

ODMCX yields 11.95% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ODMCX wins by $24.0K in total portfolio value
10 years
ODMCX
ODMCX
● Live price
11.95%
Share price
$9.29
Annual div
$1.11
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.0K
Annual income
$2,518.71
Full ODMCX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ODMCX vs JNJ

📍 ODMCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodODMCXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ODMCX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ODMCX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ODMCX
Annual income on $10K today (after 15% tax)
$1,015.60/yr
After 10yr DRIP, annual income (after tax)
$2,140.90/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ODMCX beats the other by $1,437.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ODMCX + JNJ for your $10,000?

ODMCX: 50%JNJ: 50%
100% JNJ50/50100% ODMCX
Portfolio after 10yr
$32.0K
Annual income
$1,673.24/yr
Blended yield
5.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ODMCX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ODMCX buys
0
JNJ buys
0
No recent congressional trades found for ODMCX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricODMCXJNJ
Forward yield11.95%3.36%
Annual dividend / share$1.11$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$44.0K$20.0K
Annual income after 10y$2,518.71$827.78
Total dividends collected$18.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ODMCX vs JNJ ($10,000, DRIP)

YearODMCX PortfolioODMCX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,895$1,194.82$10,676$355.77+$1.2KODMCX
2$14,056$1,328.24$11,407$389.39+$2.6KODMCX
3$16,506$1,466.86$12,198$426.53+$4.3KODMCX
4$19,272$1,609.93$13,056$467.62+$6.2KODMCX
5$22,378$1,756.67$13,987$513.12+$8.4KODMCX
6$25,850$1,906.32$14,998$563.56+$10.9KODMCX
7$29,718$2,058.10$16,098$619.52+$13.6KODMCX
8$34,009$2,211.24$17,295$681.69+$16.7KODMCX
9$38,755$2,365.01$18,599$750.82+$20.2KODMCX
10$43,987$2,518.71$20,022$827.78+$24.0KODMCX

ODMCX vs JNJ: Complete Analysis 2026

ODMCXStock

Under normal circumstances, at least 80% of the fund's assets will be invested in equity securities of small- to mid-cap companies. Assets means net assets, plus the amount of borrowings for investment purposes. Small- to mid-cap companies are generally considered to be those companies with market capitalizations similar to those within the universe of the Russell 2500® Index at the time of purchase.

Full ODMCX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ODMCX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ODMCX vs SCHDODMCX vs JEPIODMCX vs OODMCX vs KOODMCX vs MAINODMCX vs ABBVODMCX vs MRKODMCX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.